raketiv 50 mg/ml inj. sol. i.v./i.m. amp.
eurocept international b.v. - ketamine hydrochloride - eq. ketamine 50 mg/ml - solution for injection - 50 mg/ml - ketamine hydrochloride - ketamine
rapydan 70 mg - 70 mg medic. plaster sachet
eurocept international b.v. - tetracaine 70 mg; lidocaine 70 mg - medicated plaster - 70 mg - 70 mg - lidocaine 70 mg; tetracaine 70 mg - lidocaine, combinations
vancocaps 250 mg hard caps.
eurocept international b.v. - vancomycin hydrochloride 262,5 mg - eq. vancomycin 250 mg - capsule, hard - 250 mg - vancomycin hydrochloride 262.5 mg - vancomycin
amsidine 75mg/1.5ml concentrate and solvent for solution for infusion vials
eurocept international bv - amsacrine - solution for infusion - 50mg/1ml
kefurox 1500 mg inj./inf. sol. (pwdr.) i.m./i.v. vial
eurocept b.v. - cefuroxime sodium 1500 mg - powder for suspension for infusion; powder for suspension for injection; powder for solution for injection/infusion - cefuroxime
kefurox 750 mg inj./inf. sol. (pwdr.) i.m./i.v. vial
eurocept b.v. - cefuroxime sodium - eq. cefuroxime 750 mg - powder for solution for injection/infusion - cefuroxime
tepadina 15mg powder for concentrate for solution for infusion vials
adienne pharma & biotech - thiotepa - powder for solution for infusion - 15mg
tepadina 100mg powder for concentrate for solution for infusion vials
adienne pharma & biotech - thiotepa - powder for solution for infusion - 100mg
thiotepa riemser
esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastic agents - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients
kentera 3.9mg24hours patches
orion pharma (uk - oxybutynin - transdermal patch - 3.9mg/24hour